Scott Daniel Cormack is President at ONCOGENEX PHARMACEUTICALS, INC. (OGXI). They have made 9 open-market trades across 1 company since 2008, most recently 2017-09-08.
CIK 0001442675
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2008, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OGXI | SELL | 2016-06-13 | 2016-06-15 | $1.03 | $5K | -7.8% | -7.8% | -49.9% |
| OGXI | SELL | 2016-03-15 | 2016-03-16 | $0.83 | $10K | -8.9% | +6.3% | +36.7% |
| OGXI | SELL | 2015-06-12 | 2015-06-16 | $2.69 | $12K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2015-05-20 | 2015-05-21 | $1.88 | $14K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2014-08-13 | 2014-08-14 | $3.17 | $58K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2014-03-17 | 2014-03-18 | $12.25 | $57K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2013-08-19 | 2013-10-07 | $8.68 | $27K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2013-03-12 | 2013-10-07 | $11.90 | $25K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL · 10b5-1 | 2011-01-04 | 2011-01-06 | $16.52 | $165K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $16.02 | $80K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL · 10b5-1 | 2010-11-15 | 2010-11-17 | $15.99 | $80K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL · 10b5-1 | 2010-11-01 | 2010-11-02 | $15.45 | $77K | -34.8% | +1.7% | +1.7% |
| OGXI | BUY | 2008-09-26 | 2008-09-29 | $3.99 | $20K | -34.8% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.